Nucleolar METTL16 drives ccRCC tumorigenesis and pazopanib resistance via translational activation of JAG1/Notch signaling pathway.
- DOI
- 10.1016/j.drup.2026.101476
- Published
- 2026 Sep 18
- Container
- Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.drup.2026.101476,
title = {Nucleolar METTL16 drives ccRCC tumorigenesis and pazopanib resistance via translational activation of JAG1/Notch signaling pathway.},
author = {Gong Z and Dong K and Chen W and Liu Y and Li M and Ma W and Zheng H and Zhang H and Di S and Zhou W and Pan X and Cui X},
year = {2026},
journal = {Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy},
doi = {10.1016/j.drup.2026.101476},
url = {https://doi.org/10.1016/j.drup.2026.101476}
}RIS
TY - JOUR TI - Nucleolar METTL16 drives ccRCC tumorigenesis and pazopanib resistance via translational activation of JAG1/Notch signaling pathway. AU - Gong Z AU - Dong K AU - Chen W AU - Liu Y AU - Li M AU - Ma W AU - Zheng H AU - Zhang H AU - Di S AU - Zhou W AU - Pan X AU - Cui X PY - 2026 JO - Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy DO - 10.1016/j.drup.2026.101476 UR - https://doi.org/10.1016/j.drup.2026.101476 ER -
APA
Z, G., K, D., W, C., Y, L., M, L., W, M., H, Z., H, Z., S, D., W, Z., X, P., & X, C. (2026). Nucleolar METTL16 drives ccRCC tumorigenesis and pazopanib resistance via translational activation of JAG1/Notch signaling pathway.. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy. https://doi.org/10.1016/j.drup.2026.101476
Source records
- pubmed · retrieved 2026-09-25T02:21:18.745Z